Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...
While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...
Scientists led by Stephanie Eisenbarth, MD, Ph.D., the Roy and Elaine Patterson Professor of Medicine and director of the ...
Aging fundamentally transforms the human genome through accumulative epigenetic modifications—including DNA methylation, ...
The field of cancer immunology and immunotherapy is witnessing rapid advances as researchers strive to overcome persistent challenges related to immune ...
Scientists create a vaccine that shields against Crimean-Congo hemorrhagic fever within days and protects for over a year.
ReAlta Life Sciences Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to ...
Researchers at the University of Arizona have uncovered a previously unknown population of circulating immune cells that play ...
Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...
Blood proteomics highlights shared and disease-specific immune markers in skin conditions. Learn more about implications for ...
Background Interstitial fibrosis in lupus nephritis (LN) is often infiltrated by immune cells but typically regarded as ...